Genomic Cancer Profiling – Understanding Your Cancer Risk
Genomic cancer profiling is a test that traces the genes in both cancer cells and blood to identify mutations that may increase your cancer risk or affect how a tumor responds to treatment. This approach helps guide personalized therapies and preventive strategies for your unique genetic makeup.
What is Genomic Cancer Profiling?
Genomic cancer profiling analyzes cancer cells to find mutations or abnormalities in genes that are linked to cancer, such as BRCA1 and BRCA2 for breast cancer. This test is used to customize treatment plans for cancer patients and identify genetic risks within families.
Indications for Genomic Cancer Profiling:
● Personalized treatment: Tailors therapy based on the genetic makeup of cancer cells.
● Cancer risk assessment: Identifies mutations that may increase cancer risk, such as in the BRCA genes.
● Familial cancer syndromes: Identifies genetic markers for inherited cancers.
Normal Range:
● No mutations detected in the genes tested.
Abnormal Test Significance:
● Mutations in genes such as BRCA1 or BRCA2 increase the risk of breast, ovarian, and prostate cancers. Detection of such mutations can guide preventive strategies or lead to personalized treatment regimens.
Management:
● For BRCA-positive patients, preventive measures may include prophylactic surgeries, chemoprevention, or targeted therapies.
Price in India:
● Approx. ₹25,000 – ₹50,000.
FAQ Section:
What cancers are most commonly detected with genomic profiling?
Genomic profiling is most commonly used in breast, ovarian, colon, and lung cancers.
Is genomic cancer profiling used for treatment purposes?
Yes, it helps to guide targeted therapies based on the specific mutations present in the tumor.
Disclaimer:
Genomic cancer profiling is a diagnostic tool that should be interpreted in the context of clinical findings. Always consult an oncologist for personalized treatment plans.
How HealthPil Can Help:
HealthPil offers access to oncologists and genetic counselors who can interpret your genomic cancer profiling results, help with preventive strategies, and guide you on personalized cancer treatments.
